Lv5
906 积分 2025-07-10 加入
Metastatic Breast Carcinoma to the Bladder
1个月前
已完结
[Chinese expert consensus on D-dimer laboratory testing and clinical application]
3个月前
已完结
早期胃癌内镜治疗与适应证扩展的研究进展
3个月前
已完结
Review: Gastric malignancies: Basic aspects
3个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
4个月前
已完结
The next generation of immunotherapies for lung cancers
4个月前
已完结
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
4个月前
已完结
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
4个月前
已完结
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study
4个月前
已完结
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
4个月前
已完结
皖公网安备34019202002308
